Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 926 of 1,261

  1. US 8163707

    4′-allene-substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  2. US 8163548

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  3. US 8163711

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  4. US 8163703

    Hepatitis C therapies

    BioCryst Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  5. US 8165643

    Charging cradle

    CHENG UEI PRECISION INDUSTRY CO., LTD. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  6. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  7. US 8163782

    1,2,4-oxadiazole benzoic acid compositions

    PTC THERAPEUTICS, INC. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  8. US 8163772

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  9. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  10. US 8163935

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  11. US 8163881

    Immunoglobulin molecules with improved characteristics

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  12. US 8158621

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  13. US 8158580

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  14. US 8158601

    Lipid formulation

    Alnylam Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  15. US 8158603

    Fragments of secreted frizzled related protein

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  16. US 8158617

    Fused heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  17. US 8158596

    Materials and methods for FOXP3 tumor suppression

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  18. US 8158592

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  19. US 8158581

    IGF-1 fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  20. US 8158146

    Stable combinations of amlodipine besylate and benazepril hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  21. US 8158364

    Methods and compositions involving nucleotide repeat disorders

    The Board of Regents of the University of Texas System · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  22. US 8158754

    Multiple modified derivatives of gelatin and crosslinked material thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  23. US 8158675

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  24. US 8158773

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.